Paradigm Capital Management Inc’s Integra LifeSciences IART Stock Holding History

Paradigm Capital Management Inc’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.8M	Sell	3,439,098 -573,600	-14%	-$8.02M	1.68%	14
2026 Q1	$37.8M	Buy	4,012,698 +1,347,700	+51%	+$14.8M	1.45%	19
2025 Q4	$33.1M	Buy	2,664,998 +135,198	+5%	+$1.8M	1.39%	18
2025 Q3	$36.3M	Buy	2,529,800 +348,300	+16%	+$4.77M	1.57%	18
2025 Q2	$26.8M	Buy	2,181,500 +796,300	+57%	+$11.6M	1.3%	22
2025 Q1	$30.5M	Sell	1,385,200 -45,900	-3%	-$1.08M	1.69%	19
2024 Q4	$32.5M	Buy	1,431,100 +901,600	+170%	+$19.7M	1.5%	21
2024 Q3	$9.62M	Buy	+529,500	New	+$12.3M	0.43%	41

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paradigm Capital Management Inc's IART Position: Q2 2026 in Review

Paradigm Capital Management Inc reduced its Integra LifeSciences (IART) stake by 14% in Q2 2026, selling an estimated $8.02M and leaving 3,439,098 shares worth $61.8M. The position accounts for 1.68% of the portfolio, ranked #14.

Paradigm Capital Management Inc first reported a position in IART in Q3 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Paradigm Capital Management Inc held 3,439,098 shares of Integra LifeSciences worth $61.8M as of Q2 2026.
Paradigm Capital Management Inc sold 573,600 Integra LifeSciences shares in Q2 2026, an estimated $8.02M.
Integra LifeSciences made up 1.68% of Paradigm Capital Management Inc's portfolio in Q2 2026, its #14 holding.
Paradigm Capital Management Inc first reported a position in Integra LifeSciences in Q3 2024 and has held it in 8 quarters since.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2026, filed 13 Aug 2026.